ask="N/A"
ask_size="N/A"
average_daily_volume="1066400"
bid="42.50"
bid_size="100"
book_value="3.62"
change="-0.67"
change_from_200_day_moving_average="-0.96"
change_from_50_day_moving_average="0.72"
change_from_52_week_high="-10.65"
change_From_52_week_low="10.94"
change_in_percent="-1.48%"
close="44.50"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-145.92M"
eps_estimate_current_year="-2.34"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-1.31"
ex_dividend_date="N/A"
float_shares="85906000"
high="45.62"
high_52_weeks="55.15"
last_trade_date="3/17/2017"
last_trade_price="44.50"
last_trade_size="100"
last_trade_time="4:00pm"
low="44.10"
low_52_weeks="33.56"
market_capitalization="3.88B"
moving_average_200_day="45.46"
moving_average_50_day="43.78"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.33"
open="45.17"
pe_ratio="N/A"
peg_ratio="0.54"
percent_change_from_200_day_moving_average="-2.11%"
percent_change_from_50_day_moving_average="+1.64%"
percent_change_from_52_week_high="-19.31%"
percent_change_from_52_week_low="+32.60%"
previous_close="45.17"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="12.46"
price_per_sales="262.33"
revenue="15.00M"
shares_outstanding="87114000"
short_ratio="4.06"
stock_exchange="NMS"
symbol="NBIX"
volume="1091920"
weeks_range_52="33.56 - 55.15"
